64x
San Francisco, United States · Founded 2017 · $60.0M raised
- Headquarters
- San Francisco, California
- Employees
- 1–10
- Founded
- 2017
- Business Model
- B2B
- Total Funding
- $60.0M
- Last Round
- $55.0M Series AJan 2022
- Rounds
- 2
About
Bioengineering platform enabling scalable manufacturing for next-generation gene therapies.
Summary
64x is a Biotech company based in San Francisco, United States, founded in 2017. It has raised $60.0M in total across 2 rounds, most recently a $55.0M Series A round in Jan 2022. Investors include Lifeforce Capital, First Round Capital and Northpond Ventures.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2022
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract development and manufacturing organization (CDMO) focused exclusively on sterile ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Biopharmaceutical services company